Literature DB >> 8916121

A clinico-immunohistochemical study of giant cell glioblastoma.

M C Huang1, O Kubo, Y Tajika, K Takakura.   

Abstract

We have reported 7 cases of giant cell glioblastoma. All cases died within 14 months despite aggressive treatment. By immunohistochemical staining, lymphocyte infiltration was found in 6 cases. GFAP and vimentin stained positive in all cases. The MIB-1 positive rate was 13.8-90% (average, 34.9%); small and mononucleated giant cells stained more than multinucleated and monstrous cells. It was concluded that this tumor can be highly malignant and its degree of malignancy is determined by the biological behavior of the mononucleated giant cells and small cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8916121

Source DB:  PubMed          Journal:  Noshuyo Byori        ISSN: 0914-8108


  2 in total

1.  The association between race and survival in glioblastoma patients in the US: A retrospective cohort study.

Authors:  Andrew Bohn; Alexander Braley; Pura Rodriguez de la Vega; Juan Carlos Zevallos; Noël C Barengo
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

2.  Inhibition of Aurora-B function increases formation of multinucleated cells in p53 gene deficient cells and enhances anti-tumor effect of temozolomide in human glioma cells.

Authors:  Takaya Tsuno; Atsushi Natsume; Shun Katsumata; Masaaki Mizuno; Mitsugu Fujita; Hirokatsu Osawa; Norimoto Nakahara; Toshihiko Wakabayashi; Yu-ichiro Satoh; Masaki Inagaki; Jun Yoshida
Journal:  J Neurooncol       Date:  2007-02-14       Impact factor: 4.506

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.